Home
>
National Drug Code (NDC)
>
Relistor
Relistor - 0008-1225-10 - (Methylnaltrexone bromide)
Drug Information of Relistor
| Product NDC: | 0008-1225 |
| Proprietary Name: | Relistor |
| Non Proprietary Name: | Methylnaltrexone bromide |
| Active Ingredient(s): | 8 mg/.4mL & nbsp; Methylnaltrexone bromide |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Relistor
| Product NDC: | 0008-1225 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021964 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101001 |
Package Information of Relistor
| Package NDC: | 0008-1225-10 |
| Package Description: | 7 SYRINGE in 1 CARTON (0008-1225-10) > .4 mL in 1 SYRINGE |
NDC Information of Relistor
| NDC Code | 0008-1225-10 |
| Proprietary Name | Relistor |
| Package Description | 7 SYRINGE in 1 CARTON (0008-1225-10) > .4 mL in 1 SYRINGE |
| Product NDC | 0008-1225 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methylnaltrexone bromide |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20101001 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | METHYLNALTREXONE BROMIDE |
| Strength Number | 8 |
| Strength Unit | mg/.4mL |
| Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient] |
